Sales & Marketing News | pharmaphorum

News

Bayer CEO warns of tough 2025 as turnaround plan beds in

Things will get tougher before they get better at Bayer, according to CEO Bill Anderson, as the group reports its 2024 financial results.

News

an older man's hand with a pill in his palm

FDA approves first generics of anticoagulant Xarelto

The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto.

News

Roche ends the 30-year US hiatus in new stroke drugs

Genentech has won FDA approval for its clot-buster TNKase as a treatment for acute ischaemic stroke, after almost abandoning the project in 2023.

News

Pharma urges NHS to put medicines at heart of 10-year plan

The UK pharma industry has warned that declining access to new medicines in England will undermine the government's efforts to rebuild the NHS.

News

Lilly uses Oscars ad to warn about 'untested' GLP-1s

Eli Lilly has used an Oscars ad to urge people not to use unapproved and untested weight-loss medicines in a swipe at the compounding sector.

News

GSK bows to Trump pressure and pauses diversity policies

GSK has joined a lengthening list of companies that have paused diversity, equity, and inclusion (DEI) targets under pressure from US President Trump.

Bayer CEO warns of tough 2025 as turnaround plan beds in

FDA approves first generics of anticoagulant Xarelto

Roche ends the 30-year US hiatus in new stroke drugs

Pharma urges NHS to put medicines at heart of 10-year plan

Lilly uses Oscars ad to warn about 'untested' GLP-1s

GSK bows to Trump pressure and pauses diversity policies

Dexcom is first to join FDA/CMS health tech pilot

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks